Johnson & Johnson (JNJ)
266.35
+0.58
(+0.22%)
USD |
NYSE |
Aug 28, 11:59
Johnson & Johnson Cash from Operations (Quarterly) : 8.616B for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.616B |
| March 31, 2026 | 2.514B |
| December 31, 2025 | 7.309B |
| September 30, 2025 | 9.169B |
| June 30, 2025 | 3.878B |
| March 31, 2025 | 4.174B |
| December 31, 2024 | 6.983B |
| September 30, 2024 | 7.993B |
| June 30, 2024 | 5.633B |
| March 31, 2024 | 3.657B |
| December 31, 2023 | 7.863B |
| September 30, 2023 | 7.489B |
| June 30, 2023 | 4.182B |
| March 31, 2023 | 3.257B |
| December 31, 2022 | 5.35B |
| September 30, 2022 | 6.284B |
| June 30, 2022 | 5.581B |
| March 31, 2022 | 3.979B |
| December 31, 2021 | 5.732B |
| September 30, 2021 | 8.29B |
| June 30, 2021 | 5.314B |
| March 31, 2021 | 4.074B |
| December 31, 2020 | 8.343B |
| September 30, 2020 | 8.383B |
| June 30, 2020 | 3.452B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.358B |
| December 31, 2019 | 6.398B |
| September 30, 2019 | 7.527B |
| June 30, 2019 | 5.948B |
| March 31, 2019 | 3.543B |
| December 31, 2018 | 6.244B |
| September 30, 2018 | 6.272B |
| June 30, 2018 | 6.079B |
| March 31, 2018 | 3.606B |
| December 31, 2017 | 6.105B |
| September 30, 2017 | 6.266B |
| June 30, 2017 | 5.772B |
| March 31, 2017 | 2.913B |
| December 31, 2016 | 6.653B |
| September 30, 2016 | 5.361B |
| June 30, 2016 | 4.564B |
| March 31, 2016 | 2.189B |
| December 31, 2015 | 5.082B |
| September 30, 2015 | 6.125B |
| June 30, 2015 | 5.20B |
| March 31, 2015 | 2.872B |
| December 31, 2014 | 4.365B |
| September 30, 2014 | 4.654B |
| June 30, 2014 | 5.529B |
| March 31, 2014 | 3.923B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly & Co. | 10.69B |
| Merck & Co., Inc. | 5.37B |
| Pfizer Inc. | 835.00M |
| Bristol Myers Squibb Co. | 3.393B |
| Liquidia Corp. | 80.24M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.11B |
| Cash from Financing (Quarterly) | -8.777B |
| Free Cash Flow | 22.61B |
| Free Cash Flow Per Share (Quarterly) | 2.990 |
| Free Cash Flow to Equity (Quarterly) | 13.25B |
| Free Cash Flow to Firm (Quarterly) | 7.593B |
| Free Cash Flow Yield | 3.48% |